Patient Note — 185314

progress_notes_185314_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID185314 (PHI redacted)
Age / Gender53 / Male
Date of Service2026-02-26
ProviderNone
FacilityTELE-POTOMAC UROLOGY CENTER-MAN
PayerAnthem BCBS
Reason1. ANNUAL REV CUFF

Diagnoses

R39.9 Lower urinary tract symptoms
N32.81 OAB (overactive bladder)
N52.9 Erectile dysfunction, unspecified erectile dysfunction type
R53.83 Fatigue, unspecified type

Medications

Rosuvastatin Calcium Lisinopril , Notes to Pharmacist: Myrbetriq(Mirabegron ER) Tadalafil Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day Medication List reviewed and reconciled with the patient

Past Medical History

  • High Blood Pressure
  • High Cholesterol

Clinical Summary (HPI)

BPH screening: 52 yM with a history of LUTS presents for annual review cuff. - - - - - - - - - - - - - - - - - - - - He notes worsening frequency, urgency while taking medication - - - - - - - - - - - - - BASELINE: The patient is experiencing nocturia 3-4x, frequency every hour, urgency, occasional straining, hesitancy denies urge incontinence, stress incontinence, slow stream, dribbling Notes his symptoms do not worsen/improve with dietary modification/behavioral changes denies UTI, pyelo, AUR, prostatitis, hematuria, dysuria, testicular/penile pain, kidney stones smoking: no ======================= Treatment: Tamsulosin (d/c), Myrbetriq ER (current) Urocuff (02/2026): VV 158 ml, PVR 93 ml, Qmax 10.9 ml/s. -obstructive. PSA: 1.0 (12/2023). Urocuff information Date 01/23/2024 Peak flow (mL/s) 21.9 Volume voided (cc) 350 Bladder pressure (cm H2O) 200 PVR (mL) 114 Category high pressure/high flow PFS score (%) 65 IPSS Questionnaire Date 01/02/2024 IPSS Total 19 QoL/bother score 6 Erectile Dysfunction screening: The patient reports difficulty achieving a penetrable erection, difficulty maintaining rigid erection after penetration has not trialed prior medication LOW T: fatigue, weight gain/inability to lose weight =================== TEstosterone: 327 (1/2/24)Testosterone panel: FSH 4.6, LH 1.8, PRO 7.7. Progress Note: [PROVIDER_NAME], MD 02/26/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/08/202

Raw Note (de-identified preview)

4/8/26, 3:59 PM Print Preview [PATIENT_NAME] DOB: [DOB] (53 yo M) Acc No. [ACCOUNT_ID] DOS: 02/26/2026 [PATIENT_NAME] 53 Y old Male, DOB: [DOB] Account: [ACCOUNT_ID] [ADDRESS] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Anthem BCBS PCP: [PROVIDER_NAME], MD Referring: [PROVIDER_NAME], MD Appointment Facility: TELE-POTOMAC UROLOGY CENTER-MAN Structured Data: How did you hear about us? : Other; Patient's temperature : 0.00 02/26/2026 TV-F/U : [PROVIDER_NAME], MD Reason for Appointment 1. ANNUAL REV CUFF History of Present Illness BPH screening: 52 yM with a history of LUTS presents for annual review cuff. - - - - - - - - - - - - - - - - - - - - He notes worsening frequency, urgency while taking medication - - - - - - - - - - - - - BASELINE: The patient is experiencing nocturia 3-4x, frequency every hour, urgency, occasional straining, hesitancy denies urge incontinence, stress incontinence, slow stream, dribbling Notes his symptoms do not worsen/improve with dietary modification/behavioral changes denies UTI, pyelo, AUR, prostatitis, hematuria, dysuria, testicular/penile pain, kidney stones smoking: no ======================= Treatment: Tamsulosin (d/c), Myrbetriq ER (current) Urocuff (02/2026): VV 158 ml, PVR 93 ml, Qmax 10.9 ml/s. -obstructive. PSA: 1.0 (12/2023). Urocuff information Date 01/23/2024 Peak flow (mL/s) 21.9 Volume voided (cc) 350 Bladder pressure (cm H2O) 200 PVR (mL) 114 Category high pressure/high flow PFS score (%) 65 IPSS Questionnaire Date 01/02/2024 IPSS Total 19 QoL/bother score 6 Erectile Dysfunction screening: The patient reports difficulty achieving a penetrable erection, difficulty maintaining rigid erection after penetration has not trialed prior medication LOW T: fatigue, weight gain/inability to lose weight =================== TEstosterone: 327 (1/2/24)Testosterone panel: FSH 4.6, LH 1.8, PRO 7.7. Progress Note: [PROVIDER_NAME], MD 02/26/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/08/2026 06:29 AM EDT 1/4 4/8/26, 3:59 PM Print Preview [PATIENT_NAME] DOB: [DOB] (53 yo M) Acc No. [ACCOUNT_ID] DOS: 02/26/2026 IIEF/SHIM Questionnaire Date 01/02/2024 IIEF/SHIM Total 15 Current Medications Taking Rosuvastatin Calcium 5 MG Capsule Sprinkle 1 capsule Orally Once a day Lisinopril , Notes to Pharmacist: 20 mg Myrbetriq(Mirabegron ER) 25 MG Tablet Extended Release 24 Hour 1 tab(s) Orally once a day Tadalafil 5 MG Tablet 1 tab(s) orally once a day Not-Taking Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day Medication List reviewed and reconciled with the patient Past Medical History High Blood Pressure. High Cholesterol. Surgical History back surgery 2019 knee ligament repair hernia repair Family History Father: alive 70 yrs Mother: alive 71 yrs Social History Smoking: no Recreational drug use: no. Exercise: yes. Caffeine: yes. Sexually active: yes. Tobacco Control (Standard) Tobacco use: Nonsmoker AUDIT-C (Standard) Did you have